His lab is focusing on refining the alanine-scanning assay to some key residues which can precisely distinguish among fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological prognosis, And maybe for blood screening of tauopathies.Or you can invest in a tablet, that's usually smaller